Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management68
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma63
Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review48
Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA329
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression28
The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies28
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression25
Surgical management of recurrent colon cancer25
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer22
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma21
Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis21
Inherited syndromes involving pancreatic neuroendocrine tumors21
Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)20
Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC)20
Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication19
Intracorporeal anastomosis versus extracorporeal anastomosis for minimally invasive colectomy19
Surgical management of pancreatic neuroendocrine liver metastases19
Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors17
Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis17
CircTBL1XR1/miR-424 axis regulates Smad7 to promote the proliferation and metastasis of colorectal cancer16
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 716
Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis16
Genetic and epigenetic alterations in pancreatic neuroendocrine tumors16
PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer15
Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review15
Expression and prognostic value of Chromobox family members in gastric cancer14
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects14
Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model14
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens14
Machine learning-based random forest predicts anastomotic leakage after anterior resection for rectal cancer13
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation13
Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancer13
Value of nutrition support therapy in patients with gastrointestinal malignancies: a narrative review and health economic analysis of impact on clinical outcomes in the United States13
Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients13
Clinicopathological and prognostic significance of programmed death ligant-1 expression in gastric cancer: a meta-analysis13
Current status of laparoscopic liver resection for the management of colorectal liver metastases13
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis13
Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience13
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery13
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases—a systematic review12
Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK12
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma12
A review of systemic therapy in biliary tract carcinoma12
Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt12
Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups12
Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomog12
Minimally invasive surgery in the geriatric patient with colon cancer12
Combined endo-laparoscopic surgery for difficult benign colorectal polyps12
The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review12
Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties11
Value of multiphase contrast-enhanced CT with three-dimensional reconstruction in detecting depth of infiltration, lymph node metastasis, and extramural vascular invasion of gastric cancer11
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience11
Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections11
High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma11
CircBACH1/let-7a-5p axis enhances the proliferation and metastasis of colorectal cancer by upregulating CREB5 expression11
CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma11
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-911
Prognostic significance of controlling nutritional status score- based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation11
Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcom11
Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction11
Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology11
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma11
Correlation between Claudin-18 expression and clinicopathological features and prognosis in patients with gastric cancer10
Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer10
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma10
Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway10
Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy10
CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma10
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer10
Comprehensive analysis of the prognosis for chromobox family in gastric cancer10
Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method10
Clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy: systematic review and meta-analysis10
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer10
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway10
The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure9
Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method9
Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers9
Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma9
Qingjie Fuzheng Granules regulates cancer cell proliferation, apoptosis and tumor angiogenesis in colorectal cancer xenograft mice via Sonic Hedgehog pathway9
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions9
Implications of the growing incidence of global colorectal cancer9
Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis9
Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients9
Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms9
Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients8
New insights in the pathology of peritoneal surface malignancy8
Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes8
Impact of perioperative intravenous lidocaine infusion on postoperative pain and rapid recovery of patients undergoing gastrointestinal tumor surgery: a randomized, double-blind trial8
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin8
Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells8
Effects of molecular markers on the treatment decision and prognosis of colorectal cancer: a narrative review8
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer8
Prognostic performance of different lymph node classification systems in young gastric cancer8
Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma8
Global trends in pancreas cancer among Asia-Pacific population8
Diagnostic genes and immune infiltration analysis of colorectal cancer determined by LASSO and SVM machine learning methods: a bioinformatics analysis8
Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis8
Comprehensive literature review of randomized clinical trials examining novel treatment advances in patients with colon cancer8
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility8
Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma8
Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin vs. tegafur plus pirarubicin for unresectable hepatocellular carcinoma8
Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing8
miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)8
Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer8
Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review8
Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy8
Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis8
Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage8
The incidence, risk factors and predictive nomograms for early death among patients with stage IV gastric cancer: a population-based study8
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway8
Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients8
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis8
Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 18
Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review8
Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis8
Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer8
Prognostic significance of systemic immune-inflammation index- based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation8
Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancer8
Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma8
Long non-coding RNA small nucleolar RNA host gene 7 facilitates the proliferation, migration, and invasion of esophageal cancer cells by regulating microRNA-6258
A discussion of the gut microbiome’s development, determinants, and dysbiosis in cancers of the esophagus and stomach7
Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study7
Effectiveness of telerehabilitation on short-term quality of life of patients after esophageal cancer surgery during COVID-19: a single-center, randomized, controlled study7
Colorectal cancer in pregnancy: a case report and literature review7
Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry7
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma7
Rectal cancer in young patients: incidence and outcome disparities7
LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB7
Yes-activated protein promotes primary resistance of BRAF V600E mutant metastatic colorectal cancer cells to mitogen-activated protein kinase pathway inhibitors7
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy7
Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer7
A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses7
The assessment of intraoperative technique-related risk factors and the treatment of anastomotic leakage after esophagectomy: a narrative review7
Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer7
Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations7
UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation7
A narrative review of postoperative bleeding in patients with gastric cancer treated with endoscopic submucosal dissection7
LncRNA-CASC7 inhibits the proliferation and migration of colon cancer by negatively regulating the PI3K/Akt signaling pathway7
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review7
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes7
Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome7
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration7
Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining7
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients7
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin7
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer7
Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus7
Molecular characterization of squamous cell carcinoma of the anal canal7
Immune checkpoint inhibitors in liver transplant: a case series7
Review of management and treatment of peritoneal metastases from gastric cancer origin7
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?7
Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study7
Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer6
The stress hyperglycemia ratio, a novel index of relative hyperglycemia, predicts short-term mortality in critically ill patients after esophagectomy6
PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway6
Circulating tumor DNA and plasma microsatellite instability during PD-1 blockade6
High body mass index is associated with an increased overall survival in rectal cancer6
miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice6
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling6
Identification of a glycolysis-related gene signature for predicting pancreatic cancer survival6
A narrative review of intraperitoneal chemotherapy and cytoreductive surgery (CRS) for peritoneal metastases in gastric cancer6
The diagnosis and outcome of Krukenberg tumors6
FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC6
The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma6
The brain–gut axis in gastrointestinal cancers6
Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo6
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cance6
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection6
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival6
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study6
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions6
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma6
Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database6
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies6
Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/ DUSP6/ERK axis6
Digestive tract reconstruction of laparoscopic total gastrectomy for gastric cancer: a comparison of the intracorporeal overlap, intracorporeal hand-sewn anastomosis, and extracorporeal anastomosis6
Outcomes of colorectal cancer surgery in nonagenarian patients: a multicenter retrospective study6
Expression and prognostic significance of thrombospondin gene family in gastric cancer6
Comprehensive bioinformatics analysis of functional molecules in colorectal cancer6
Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma6
Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer5
Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer5
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma5
High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma5
Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer5
A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis5
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining5
Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma5
Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance5
c-MYC and HIF1α promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer5
A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor5
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics5
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis5
Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective stud5
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis5
Indolent T cell lymphoproliferative disorder of the gastrointestinal tract: an uncommon case with lymph node involvement and the classic Hodgkin’s lymphoma5
Effect of the systemic immune-inflammation index on postoperative complications and the long-term prognosis of patients with colorectal cancer: a retrospective cohort study5
Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma5
Cost-effectiveness of camrelizumab versus chemotherapy for the treatment of advanced or metastatic esophageal squamous cell carcinoma5
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds5
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining5
Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway5
Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-415
Laparoscopic-assisted versus open proximal gastrectomy with double-tract reconstruction for Siewert type II–III adenocarcinomas of esophago-gastric junction: a retrospective observational study of sho5
Pathobiology, irradiation dosimetric parameters and therapy of radiation-induced gastric damage: a narrative review5
The clinical features, management, and survival of elderly patients with colorectal cancer5
Correlation between L3 skeletal muscle index and prognosis of patients with stage IV gastric cancer5
Oxaliplatin-based hyperthermic intraperitoneal chemotherapy with single drug versus multiple drug treatment for colorectal cancer with peritoneal metastases: an observational cohort study5
Outcome of surgical treatment for bone metastases caused by colorectal cancer5
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma5
Predictive value of prognostic nutritional index on infection after radical gastrectomy: a retrospective study5
REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression5
Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases5
Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma5
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM35
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients5
Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells5
Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report5
Current state of prognostication, therapy and prospective innovations for Barrett’s-related esophageal adenocarcinoma: a literature review5
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway5
Can local ablative techniques replace surgery for locally advanced pancreatic cancer?5
Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection5
Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center5
Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer5
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial5
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma5
Gastric cancer complicated with hemophagocytic lymphohistiocytosis: case report and a brief review5
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway5
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer5
Downregulation of Ascl2 promotes cell apoptosis by enhancing autophagy in colorectal cancer cells5
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma4
Current management of gastric adenocarcinoma: a narrative review4
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma4
Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection4
Chemosensitivity of gastric cancer: analysis of key pathogenic transcription factors4
Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study4
Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer4
Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection4
A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report4
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma4
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy4
Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research4
Let food be thy medicine: the role of diet in colorectal cancer: a narrative review4
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study4
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels4
Prognostic role of myeloid-derived tumor-associated macrophages at the tumor invasive margin in gastric cancer with liver metastasis (GCLM): a single-center retrospective study4
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms4
A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer4
Minimally invasive complete mesocolic excision and central vascular ligation (CME/CVL) for right colon cancer4
Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis4
0.096805095672607